
2192215-81-7 ritlecitinib tosylate
CAS: 2192215-81-7
MF: C22H27N5O4S
MW: 457.55
Einecs: 201-058-9
MDL Non.:
Pwopriyete
fòme solid
Koulè blan nan koupe-blan
Aplikasyon:
Ritlecitinib tosylate se yon inibitè selektif JAK3, chimikman yo te rele 4- methylbenzenesulfonate rituxitinib. Li fè pati klas inibitè JAK la, sitou itilize pou trete enflamasyon ak maladi auto -immunes, espesyalman alopesi areata.
Sinonim:
Ritlecitinib tosylate
Ritlecitinib toslate
Pf -06651600 Tosylate
Litfulo
2192215-81-7
Ritlecitinib (tosylate)
Litfulo
Chembl5314649
Hy -100754 C
CS -0188778
D11970
1- [(2s, 5r) -2- methyl -5- (7h-pirrolo [2, 3- d] pyrimidin -4- ylamino) Piperidin {{} 4- methylbenzenesulfonate (1: 1)
1- {(2s, 5r) -2- methyl -5- [(7h-pirrolo [2, 3- d] Pyrim idin -4- yl) amino] piperidin -1- yl} prop -2- en -1- yon sèl 4 methylbenzene -1- asid sulfonic
4- methylbenzene -1- sulfonic asid --1- {(2s, 5r) -2- methyl -5- [(7h-pirrolo [2, 3- d] pyr imidin -4- yl) amino] piperidin -1- yl} prop -2- en -1- yon sèl (1/1)
4- methylbenzenesulfonic asid; 1- [(2s, 5r) -2- methyl -5- (7h-pirrolo [2, 3- d] pyrimidin -4- ylamino) Piperidin -1-}} {
Baj popilè: 2192215-81-7 ritlecitinib tosylate, Lachin 2192215-81-7 Ritlecitinib Tosylate Manifaktirè, Swèd

